biostudies-literatureUnknown77Yacine O<h4>Introduction and importance</h4>Glucagonoma is a rare neuroendocrine tumor (NET). Most glucagonomas are in the tail or body of the pancreas and are diagnosed at a metastatic stage. We report a case of an early recurrence after surgical resection of a glucagonoma and its management.<h4>Case report</h4>We present a case of a 44-year-old female patient with no medical and surgical history, operated on in May 2018 for pancreatic glucagonoma revealed by skin necrolytic migratory erythema. The patient was regularly monitored by clinical exams and CT scans. In December 2020 (31 months postoperatively), we noticed the recurrence of the cutaneous lesions.Admission laboratory measurements demonstrated hyperglycemia as well as elevated blood Glucagon levels. Explorations showed 3 retro-pancreaticAnnals of medicine and surgery (2012)103604https://www.ebi.ac.uk/biostudies/studies/S-EPMC9142409biostudies-literatureCase report of a recurrent resected glucagonoma.PMC9142409Ben Mahmoud AFterich SFMagherbi HKsontini FLYacine OKacem MfalseCase report of a recurrent resected glucagonoma.<h4>Introduction and importance</h4>Glucagonoma is a rare neuroendocrine tumor (NET). Most glucagonomas are in the tail or body of the pancreas and are diagnosed at a metastatic stage. We report a case of an early recurrence after surgical resection of a glucagonoma and its management.<h4>Case report</h4>We present a case of a 44-year-old female patient with no medical and surgical history, operated on in May 2018 for pancreatic glucagonoma revealed by skin necrolytic migratory erythema. The patient was regularly monitored by clinical exams and CT scans. In December 2020 (31 months postoperatively), we noticed the recurrence of the cutaneous lesions.Admission laboratory measurements demonstrated hyperglycemia as well as elevated blood Glucagon levels. Explorations showed 3 retro-pancreatic2022-01-01T00:00:00Z2022 May2025-05-18T13:01:20.04Z2024-10-18T11:07:01.408ZS-EPMC91424093563803110.1016/j.amsu.2022.103604